InvestorsHub Logo
Followers 1
Posts 88
Boards Moderated 0
Alias Born 03/22/2017

Re: None

Monday, 06/12/2017 7:28:07 PM

Monday, June 12, 2017 7:28:07 PM

Post# of 50157
Slim chance the R/S doesn't pass. Part of the reason they ok these toxic finance deals is because it gives them quick cash and they just dilute. Then after R/S and the share price getting shorted back under $1.00 all kinds of new investors that don't bother with DD only see a low share count, low debt and sub $1.00 share price for a cancer treatment company. They don't bother to look at past history of shareholder being wiped out . Rinse/wash/ repeat. Not only will the R/S pass so will them
Giving themselves all bonuses
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News